Nathalie Thierjung

Amyloid cascade upstream players as new biomarker candidates in the framework of the new conceptualisation of Alzheimer’s disease

Nathalie Thierjung, 2019 .

Fluid biomarker agreement and interrelation in dementia due to Alzheimer’s disease

N. Laskaris, A. Kurz, R. Perneczky, 2017, Journal of Neural Transmission.

Mapping CSF biomarker profiles onto NIA–AA guidelines for Alzheimer’s disease

N. Laskaris, A. Kurz, R. Perneczky, 2016, European Archives of Psychiatry and Clinical Neuroscience.

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

N. Laskaris, A. Kurz, R. Perneczky, 2014, Alzheimer's Research & Therapy.

Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease

A. Kurz, R. Perneczky, I. Yakushev, 2017, European Archives of Psychiatry and Clinical Neuroscience.

Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia.

R. Perneczky, B. Hemmer, P. Alexopoulos, 2019, Journal of Alzheimer's disease : JAD.

Cerebrospinal Fluid BACE1 Activity and sAβPPβ as Biomarker Candidates of Alzheimer’s Disease

R. Perneczky, P. Alexopoulos, K. Assimakopoulos, 2018, Dementia and Geriatric Cognitive Disorders.

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

N. Laskaris, I. Yakushev, P. Alexopoulos, 2014, Alzheimer's Research & Therapy.